Show simple item record

dc.contributor.authorGuinn, Barbara-Annen
dc.contributor.authorBraidwood, Lynneen
dc.contributor.authorParker, Alanen
dc.contributor.authorPeng, Kah-Whyeen
dc.contributor.authorSeymour, Leonarden
dc.date.accessioned2015-09-25T13:12:55Zen
dc.date.available2015-09-25T13:12:55Zen
dc.date.issued2014-12en
dc.identifier.citationGuinn, B.A., Braidwood, L., Parker, A., Peng, K.W., & Seymour, L. (2014) '8th international conference on oncolytic virus therapeutics'. Human Gene Therapy, vol 25 (12) pp.1062-84en
dc.identifier.issn1557-7422en
dc.identifier.pmid25274574en
dc.identifier.doi10.1089/hum.2014.118en
dc.identifier.urihttp://hdl.handle.net/10547/578744en
dc.description.abstractThe 8th International Conference on Oncolytic Virus Therapeutics meeting was held from April 10-13, 2014, in Oxford, United Kingdom. It brought together experts in the field of oncolytics from Europe, Asia, Australasia, and the Americas and provided a unique opportunity to hear the latest research findings in oncolytic virotherapy. Presentations of recent work were delivered in an informal and intimate setting afforded by a small group of attendees and an exquisitely focused conference topic. Here we describe the oral presentations and enable the reader to share in the benefits of bringing together experts to share their findings.
dc.language.isoenen
dc.publisherMary Ann Lieberten
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/25274574en
dc.relation.urlhttp://online.liebertpub.com/doi/abs/10.1089/hum.2014.118en
dc.subject.meshEuropeen
dc.subject.meshHumansen
dc.subject.meshNeoplasmsen
dc.subject.meshOncolytic Virotherapyen
dc.subject.meshOncolytic Virusesen
dc.subject.meshResearchen
dc.title8th international conference on oncolytic virus therapeuticsen
dc.typeArticleen
dc.identifier.journalHuman gene therapyen
html.description.abstractThe 8th International Conference on Oncolytic Virus Therapeutics meeting was held from April 10-13, 2014, in Oxford, United Kingdom. It brought together experts in the field of oncolytics from Europe, Asia, Australasia, and the Americas and provided a unique opportunity to hear the latest research findings in oncolytic virotherapy. Presentations of recent work were delivered in an informal and intimate setting afforded by a small group of attendees and an exquisitely focused conference topic. Here we describe the oral presentations and enable the reader to share in the benefits of bringing together experts to share their findings.


This item appears in the following Collection(s)

Show simple item record